Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay R Mehta

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2013
Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and CanadaMaile Y Karris, Susan E Beekmann, Sanjay R Mehta, et al.
Scientific Reports|June 25, 2016
A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemicsAntoine Chaillon, Martin Hoenigl, Sanjay R Mehta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2018
Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIVMarta Massanella, Maile Y Karris, Josué Pérez-Santiago, et al.
Sexual Health|July 13, 2019
Meta-analysis of the Cepheid Xpert<sup>®</sup> CT/NG assay for extragenital detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infectionsClaire C Bristow, Sheldon R Morris, Susan J Little, et al.
The Journal of Infection|November 5, 2018
Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignanciesJeffrey D Jenks, Sanjay R Mehta, Randy Taplitz, et al.
Infection Control and Hospital Epidemiology|September 18, 2020
Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset <i>Clostridioides difficile</i> infectionDipesh Solanky, Derek K Juang, Scott T Johns, et al.
AJOB Empirical Bioethics|May 4, 2019
Trust and Expectations of Researchers and Public Health Departments for the Use of HIV Molecular EpidemiologyCynthia E Schairer, Sanjay R Mehta, Staal A Vinterbo, et al.
Open Forum Infectious Diseases|July 16, 2016
A Novel Shiga Toxin 1a-Converting Bacteriophage of Shigella sonnei With Close Relationship to Shiga Toxin 2-Converting Pages of Escherichia coliChristoph C Carter, Joshua Fierer, Wei Wei Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2022
Cardiovascular Outcomes After Tixagevimab and Cilgavimab use for Pre-Exposure Prophylaxis Against Coronavirus Disease 2019: A Population-Based Propensity-matched Cohort StudyMorgan Birabaharan, Eddie Hill, Maedha Begur, et al.
The Journal of Infection|August 14, 2016
Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissionsMartin Hoenigl, Antoine Chaillon, Sanjay R Mehta, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2013
Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and CanadaMaile Y Karris, Susan E Beekmann, Sanjay R Mehta, et al.
Scientific Reports|June 25, 2016
A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemicsAntoine Chaillon, Martin Hoenigl, Sanjay R Mehta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2018
Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIVMarta Massanella, Maile Y Karris, Josué Pérez-Santiago, et al.
Sexual Health|July 13, 2019
Meta-analysis of the Cepheid Xpert<sup>®</sup> CT/NG assay for extragenital detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infectionsClaire C Bristow, Sheldon R Morris, Susan J Little, et al.
The Journal of Infection|November 5, 2018
Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignanciesJeffrey D Jenks, Sanjay R Mehta, Randy Taplitz, et al.
Infection Control and Hospital Epidemiology|September 18, 2020
Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset <i>Clostridioides difficile</i> infectionDipesh Solanky, Derek K Juang, Scott T Johns, et al.
AJOB Empirical Bioethics|May 4, 2019
Trust and Expectations of Researchers and Public Health Departments for the Use of HIV Molecular EpidemiologyCynthia E Schairer, Sanjay R Mehta, Staal A Vinterbo, et al.
Open Forum Infectious Diseases|July 16, 2016
A Novel Shiga Toxin 1a-Converting Bacteriophage of Shigella sonnei With Close Relationship to Shiga Toxin 2-Converting Pages of Escherichia coliChristoph C Carter, Joshua Fierer, Wei Wei Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2022
Cardiovascular Outcomes After Tixagevimab and Cilgavimab use for Pre-Exposure Prophylaxis Against Coronavirus Disease 2019: A Population-Based Propensity-matched Cohort StudyMorgan Birabaharan, Eddie Hill, Maedha Begur, et al.
The Journal of Infection|August 14, 2016
Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissionsMartin Hoenigl, Antoine Chaillon, Sanjay R Mehta, et al.
Pageof 13